ПОВОЛЖСКИЙ ОНКОЛОГИЧЕСКИЙ ВЕСТНИК 1( 28)’ 2017
advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatment // Chin J. Cancer Res.— 2015 Jun.— 27( 3).— P. 221-230.
22. Swisher S. G., Maish M., Erasmus J. J., et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer // Ann. Thorac. Surg.— 2004.— 78.— P. 1152-1160.
23. Cerfolio R. J., Bryant A. S., Ohja B., et al. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy // J. Thorac. Cardiovasc. Surg.— 2005.— 129.— P. 1232-1241.
24. Bruzzi J. F., Swisher S. G., Truong M. T., et al. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy // Cancer.— 2007.— 109.— P. 125-134.
25. Tao C., Lin G., Xu Y. et al. Predicting the response of neoadjuvant therapy for patients with esophageal carcinoma: an in-depth literature review // J. Cancer.— 2015.— 6( 11).— P. 1179-1186.
26. Schroer M., Scheibler F., Wolff R. et al. The role of PET and PET-CT scanning in assessing response to neoadjuvant therapy in esophageal carcinoma. a systematic review // Dtsch Arztebl Int.— 2015 Aug.— 112( 33-34).— P. 545-552.
27. van Heijl M., Omloo J. M., van Berge Henegouwen M. I., et al. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer // Ann. Surg.— 2011.— 253.— P. 56-63.
10 Клинические исследования и опыт в онкологии